accessible

06/17/2019

IVI partners with QuadMedicine to develop microneedle-based vaccines

Dr. Jerome Kim (left), General Director of IVI and Mr. Seung-Ki Baek, CEO of QuadMedicine   June 17, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with QuadMedicine, a Korea-based biotech venture, to collaborate on the development of microneedle-based vaccines. With […]
후원하기